• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Cipla Ltd.
    25 Jul 2025
    1563.80
    -0.69%
    US tariffs will not have debilitating' impact on pharma industry: Cipla global MD & CEO
    Business Line
    Cipla's top executive Umang Vohra said that tariffs on meds pharma sector will not be as high as others, given the importance of medicines in everyone's lives.
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Hold report for Cipla Ltd. with a price target of 1570.0 on 08 Sep, 2025.
    Cipla Q1 net profit up 10%, driven by consumer health and generics
    Business Standard | 25 Jul 2025 3 more
    Cipla Q1 PAT rises 10% to 1,298 cr; income at 6,957 cr
    Business Line | 25 Jul 2025
    Cipla Q1 FY26 result: Net profit jumps 10% at 1,298 cr, income rises 4%
    Business Standard | 25 Jul 2025
    Cipla Q1 Results: Profit Rises 10%, Beats Estimates
    NDTV Profit | 25 Jul 2025
    logo
    Sigachi Industries Ltd.
    25 Jul 2025
    Dividend High Gain High Volume
    45.21
    5.46%
    Sigachi Industries posts 101-cr net loss in Q1 FY26
    Business Line
    Production shifted from Pashamylaram Pashmylaram unit which was hit by major mishap in June
    Copy LinkShare onShare on Share on Share on
    Sigachi Industries Ltd.'s price crossed below 100Day SMA today
    logo
    Blue Jet Healthcare Ltd
    25 Jul 2025
    Dividend
    710.90
    -0.84%
    'Buy' Blue Jet Healthcare Share Maintains Motilal Oswal Post Q1 Results; Sees Upto 35% Upside
    'Buy' Blue Jet Healthcare Share Maintains Motilal Oswal Post Q1 Results; Sees Upto 35% Upside
    NDTV Profit
    Copy LinkShare onShare on Share on Share on
    Blue Jet Healthcare Ltd has gained 41.71% in the last 1 Year
    logo
    Laurus Labs Ltd.
    25 Jul 2025
    895.65
    -0.04%
    Laurus Labs Q1 FY26 net profit up at 163 cr
    Business Line
    The revenue of the Hyderabad-based company increased31% at 1570 crore against 1195 crore in theyear-ago period
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd. has gained 34.36% in the last 3 Months
    logo
    Indoco Remedies Ltd.
    25 Jul 2025
    294.05
    -1.67%
    'Sell' Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside Here's Why
    'Sell' Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside Here's Why
    NDTV Profit
    Dolat Capital maintains Sell' rating on Indoco Remedies and revises target price
    Copy LinkShare onShare on Share on Share on
    Indoco Remedies Ltd.'s price crossed below 50Day SMA today
    logo
    Sun Pharmaceutical Industries Ltd.
    25 Jul 2025
    1609.90
    -0.41%
    Sun Pharma settles US antitrust litigation for $200 million
    Business Line
    The settlement amounts may be reduced if more than a certain percentage of the total insured class members opt out of the putative class, says the company
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd.'s price crossed below 30Day SMA today
    Sun Pharma Shares Decline On $200 Million US Antitrust Litigation Payout
    NDTV Profit | 25 Jul 2025 2 more
    Sun Pharma Settles US Antitrust Litigation For $200 Million
    NDTV Profit | 25 Jul 2025
    Sun Pharma resolves US antitrust case with $200 mn agreement
    Business Standard | 25 Jul 2025
    logo
    Torrent Pharmaceuticals Ltd.
    25 Jul 2025
    3538.80
    -0.77%
    Torrent Pharma Share Price Gets Investec 'Buy' Call JB Chemicals Acquisition to Boost Growth
    Torrent Pharma Share Price Gets Investec 'Buy' Call JB Chemicals Acquisition to Boost Growth
    NDTV Profit
    Once the deal is finalised, Torrent Pharmaceuticals will become India's second most valued pharma company.
    Copy LinkShare onShare on Share on Share on
    Torrent Pharmaceuticals Ltd. is trading above its 200 day SMA of 3311.9
    logo
    Syngene International Ltd.
    25 Jul 2025
    673.00
    1.33%
    Syngene International CEO Confident Of Maintaining Mid-Teens Revenue Growth In FY26 After Strong Q1 Results
    Syngene International CEO Confident Of Maintaining Mid-Teens Revenue Growth In FY26 After Strong Q1 Results
    NDTV Profit
    Syngene International has made a robust start to the financial year 2025-26, with a strong growth in revenue from operations and the net profit in the first quarter.
    Copy LinkShare onShare on Share on Share on
    Syngene International Ltd. is trading above its 150 day SMA of 669.8
    Pilot wins, biologics ramp-up drive Syngene's Q1; PAT growth to moderate, says Peter Bains
    Business Line | 24 Jul 2025
    logo
    Dr. Reddy's Laboratories Ltd.
    24 Jul 2025
    US FDA Observation
    1300.10
    -1.26%
    Q1 miss for Dr Reddy's, but analysts remain hopeful for future prospects
    Business Standard
    Despite missing Q1 expectations, Dr Reddy's continues to see growth in key markets like Europe and India, while managing costs to offset challenges in the US
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    logo
    Lupin Ltd.
    24 Jul 2025
    2035.30
    -0.40%
    Lupin gets USFDA nod for generic diabetes drugs
    Business Line
    The company received approval from the USFDA for its abbreviated new drug applications for Liraglutide Injection single-patient-use prefilled pens and glucagon for injection vials, the drug maker said in a statement
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. is trading above all available SMAs
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd